These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 21102997)

  • 21. Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial.
    Ivgy-May N; Ruwe F; Krystal A; Roth T
    Sleep Med; 2015 Jul; 16(7):838-44. PubMed ID: 26047892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxepin is more effective than zolpidem in improving executive function in patients with insomnia disorder.
    Yu Z; Han L; Yan P; Liu W; Ren L; Xu Y; Yang L; Ma L; Liu Y; Wang S
    Sleep Breath; 2024 May; 28(2):929-934. PubMed ID: 38123719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressants for insomnia in adults.
    Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
    Erman MK; Zammit G; Rubens R; Schaefer K; Wessel T; Amato D; Caron J; Walsh JK
    J Clin Sleep Med; 2008 Jun; 4(3):229-34. PubMed ID: 18595435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
    Black J; Pillar G; Hedner J; Polo O; Berkani O; Mangialaio S; Hmissi A; Zammit G; Hajak G
    Sleep Med; 2017 Aug; 36():86-94. PubMed ID: 28735928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose doxepin: in the treatment of insomnia.
    Weber J; Siddiqui MA; Wagstaff AJ; McCormack PL
    CNS Drugs; 2010 Aug; 24(8):713-20. PubMed ID: 20658801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial.
    Ivgy-May N; Roth T; Ruwe F; Walsh J
    Sleep Med; 2015 Jul; 16(7):831-7. PubMed ID: 26047890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
    Krystal AD; Walsh JK; Laska E; Caron J; Amato DA; Wessel TC; Roth T
    Sleep; 2003 Nov; 26(7):793-9. PubMed ID: 14655910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease -- a randomized study.
    Rios Romenets S; Creti L; Fichten C; Bailes S; Libman E; Pelletier A; Postuma RB
    Parkinsonism Relat Disord; 2013 Jul; 19(7):670-5. PubMed ID: 23561946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials.
    Gotfried MH; Auerbach SH; Dang-Vu TT; Mishima K; Kumar D; Moline M; Malhotra M
    Drugs Aging; 2024 Sep; 41(9):741-752. PubMed ID: 39120786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
    Roehrs TA; Roth T
    J Clin Sleep Med; 2016 Mar; 12(3):319-25. PubMed ID: 26446253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tiagabine on sleep in elderly subjects with primary insomnia: a randomized, double-blind, placebo-controlled study.
    Roth T; Wright KP; Walsh J
    Sleep; 2006 Mar; 29(3):335-41. PubMed ID: 16553019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks.
    Rodenbeck A; Cohrs S; Jordan W; Huether G; Rüther E; Hajak G
    Psychopharmacology (Berl); 2003 Dec; 170(4):423-8. PubMed ID: 13680082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study.
    Scharf MB; Black J; Hull S; Landin R; Farber R
    Sleep; 2007 Jun; 30(6):743-52. PubMed ID: 17580596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
    JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo.
    Walsh JH; Maddison KJ; Rankin T; Murray K; McArdle N; Ree MJ; Hillman DR; Eastwood PR
    Sleep; 2021 Nov; 44(11):. PubMed ID: 34115851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
    BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK; Moscovitch A; Burke J; Farber R; Roth T
    Sleep Med; 2007 Nov; 8(7-8):753-9. PubMed ID: 17825616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
    Mayer G; Wang-Weigand S; Roth-Schechter B; Lehmann R; Staner C; Partinen M
    Sleep; 2009 Mar; 32(3):351-60. PubMed ID: 19294955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.